| Cardiovascular Risk Management |
1 |
1 |
| Biliary Disease |
0 |
0.64 |
| Autoimmune Hepatitis |
0 |
0.99 |
| Liver |
0 |
0.5 |
| Liver Disease |
0 |
0.98 |
| Lipids Management |
0 |
0.48 |
| Hepatitis |
0 |
0.38 |
| Hepatitis A |
0 |
0.38 |
| Statins |
0 |
0.38 |
| Face |
0 |
0.25 |
| Coronary Artery Disease (CAD) |
0 |
0.22 |
| Tobacco Cessation |
0 |
0.21 |
| Tobacco Use |
0 |
0.21 |
| Cardiometabolic Risk Factors |
0 |
0.2 |
| Cardiovascular disease |
0 |
0.19 |
| Hospital |
0 |
0.19 |
| Hypertension |
0 |
0.19 |
| Percutaneous Coronary Intervention |
0 |
0.17 |
| Biologic Therapy |
0 |
0.15 |
| Myocardial Infarction (MI) |
0 |
0.15 |
| Acute Coronary Syndrome |
0 |
0.13 |
| Acute Myocardial Infarction (MI) |
0 |
0.13 |
| Cholangitis |
0 |
0.13 |
| Fellowship |
0 |
0.13 |
| Infarction |
0 |
0.13 |
| Primary Sclerosing Cholangitis |
0 |
0.13 |
| Transplantation |
0 |
0.13 |
| Angina Pectoris |
0 |
0.1 |
| Rheumatoid Arthritis |
0 |
0.09 |
| Artery |
0 |
0.06 |
| Arthritis |
0 |
0.06 |
| California |
0 |
0.06 |
| Diabetes Mellitus |
0 |
0.06 |
| Hyperlipidemia |
0 |
0.06 |
| Match |
0 |
0.06 |
| Medical Life |
0 |
0.06 |
| Psoriasis |
0 |
0.06 |
| Steroids |
0 |
0.06 |
| Unstable Angina |
0 |
0.06 |
| Washington |
0 |
0.06 |